CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Blood
Volume	128
Issue number	22
Number of pages	4
ISSN	0006-4971
Publication status	Published - 2 Dec 2016
Event	58th Annual Meeting and Exposition of the American-Society-of-Hematology - San Diego, Canada Duration: 3 Dec 2016 → 6 Dec 2016

Cite this

@article{97a0b4b3b6774173bfdb5278cd22d37c,

title = "CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism",

author = "Paavo Pietarinen and Perttu Koskenvesa and Judith Klievink and Kimmo Porkka and Mikko Niemi and Satu Mustjoki",

year = "2016",

month = dec,

day = "2",

language = "English",

volume = "128",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "22",

note = "58th Annual Meeting and Exposition of the American-Society-of-Hematology ; Conference date: 03-12-2016 Through 06-12-2016",

}

TY - JOUR

T1 - CML Patients with Primary Resistance or Suboptimal Response to TKI Therapy Have Variants in Genes Affecting Drug Absorption and Metabolism

AU - Pietarinen, Paavo

AU - Koskenvesa, Perttu

AU - Klievink, Judith

AU - Porkka, Kimmo

AU - Niemi, Mikko

AU - Mustjoki, Satu

PY - 2016/12/2

Y1 - 2016/12/2

M3 - Meeting Abstract

VL - 128

JO - Blood

JF - Blood

SN - 0006-4971

IS - 22

T2 - 58th Annual Meeting and Exposition of the American-Society-of-Hematology

Y2 - 3 December 2016 through 6 December 2016

ER -